Status checked on October 6, 2026 accessdata.fda.gov
Sculptra (poly-L-lactic acid) explained: exact FDA approvals (face only), why body use is not approved, how it works, the 2023 cheek trial, side effects and nodules, vascular risks, contraindications, cost and alternatives.
Fact-checked against FDA labels and official sources; not yet reviewed by a licensed clinician. This page is education, not medical advice. Talk to your doctor before starting, stopping or changing any treatment.
Key facts
- Type
- Cosmetic (not weight loss)
- Approach
- Injectable
- Sedation
- Local anesthetic (lidocaine) may be mixed in; no sedation
- Time
- A series of sessions (average 3.6, up to 4, in the cheek trial)
- Downtime
- 1-3 days
- Permanence
- Temporary
- Body areas
- Face
- Device status
- Sculptra (HIV facial lipoatrophy) · PMA approval
- Performed by
- Dermatology, Plastic surgery
Key takeaways
- Sculptra is FDA approved only for facial uses: HIV facial fat loss, facial wrinkles and, since 2023, cheek wrinkles.[1]
- The FDA recommends against using dermal fillers or any injectable filler for body contouring and enhancement.[4]
- In the cheek trial, 70.7% of treated people improved by at least one grade at 12 months, against 25.9% without treatment.[2]
- Nodules and granulomas can appear months after injection, and all fillers carry a rare risk of vascular injury and vision loss.[2]
In short: Sculptra is an injectable implant made of microparticles of poly-L-lactic acid (PLLA) that gradually stimulates the body’s own collagen to restore volume and soften wrinkles. The FDA has approved it, as a medical device, only for the face: facial fat loss in people with HIV (2004), nasolabial folds and other facial wrinkles (2009) and fine lines and wrinkles of the cheeks (2023). Injecting it into the buttocks, thighs, arms or other body areas is not FDA approved, and the FDA recommends against using any filler for body contouring. Treatment usually takes several sessions, results build over months, and lumps (nodules) can appear months later. It is not weight loss.
Because many people now look at Sculptra after losing weight with GLP-1 medicines, this page covers its exact FDA approvals, how it works, what the most recent approval trial measured, side effects with numbers, rare serious risks such as vision problems from injection into a blood vessel, who should not use it, cost and alternatives. InstaTuck does not sell or arrange treatments. Research carefully, see a licensed dermatologist or plastic surgeon and get evaluated in person before any injection.
Sculptra at a glance
- 3 FDA approvalsHIV facial fat loss (2004), facial wrinkles (2009), cheek wrinkles (2023)FDA PMA P030050
- 70.7% vs 25.9%cheek-wrinkle responders at 12 months, Sculptra vs no treatmentFDA SSED P030050/S039
- 3.6average number of treatment sessions in that trial (range 1 to 4)FDA SSED P030050/S039
- $9012023 average fee per non-hyaluronic acid filler procedure (Sculptra, Radiesse and others)ASPS 2023 statistics
Checked on October 6, 2026
What Sculptra is and how it works
The FDA describes Sculptra as an injectable implant containing microparticles of poly-L-lactic acid, with sodium carboxymethylcellulose, mannitol and sterile water. It is supplied as a dry powder in a vial and is reconstituted with sterile water (and, in the cheek trial, lidocaine) before injection. Unlike hyaluronic acid fillers, which add volume directly, PLLA works more slowly: ASPS notes that many non-hyaluronic acid fillers stimulate the body’s own collagen production for longer-lasting results, and that most are used for facial rejuvenation. Because it is a device, it is regulated by the FDA’s device center through premarket approval (PMA), the strictest device pathway.
FDA approvals, in order
Sculptra's FDA approval history (PMA P030050)
- August 3, 2004Approved to restore or correct the signs of facial fat loss (lipoatrophy) in people with HIV.
- July 28, 2009Sculptra Aesthetic approved for immune-competent people to correct shallow to deep nasolabial fold contour deficiencies and other facial wrinkles.
- November 23, 2021Labeling combined; both marketed under the single name Sculptra.
- April 2023Approved to correct fine lines and wrinkles in the cheek region in immune-competent people.
- 2023 to 2026Later FDA actions we found were manufacturing and labeling changes; no body indication.
No approval covers the buttocks, thighs, arms, abdomen, chest or knees. Using an approved device outside its indication is “off-label” and up to the treating clinician, but it means the FDA has not reviewed safety or effectiveness for that use. The FDA’s dermal filler page goes further and recommends against using dermal fillers or any injectable filler for body contouring and enhancement, such as increasing the size of the breasts or buttocks or filling the feet. Injectable silicone is not approved for any aesthetic use.
After weight loss: what Sculptra can and cannot address
Fast weight loss can thin the face, a change popularly called Ozempic face. In the ASPS 2025 survey, 33% of member surgeons reported using biostimulatory injectables (the group Sculptra belongs to) for facial rejuvenation, behind hyaluronic acid fillers (69%), fat grafting (49%) and energy devices (45%). Sculptra may be discussed for facial volume within its approved uses. It does not tighten or remove loose skin on the body; for that, see skin tightening and surgical lifts such as the arm lift or tummy tuck. Waiting until your weight is stable before cosmetic treatment avoids treating a moving target; our loose skin guide explains timing.
What the 2023 cheek-wrinkle trial showed
The approval for cheek wrinkles rests on a randomized, evaluator-blinded study of 149 adults with moderate or severe cheek wrinkles, assigned 2 to 1 to Sculptra (97) or no treatment (52). People treated received up to four sessions, an average of 3.6, with a median of 16 mL per session across both cheeks. A responder was someone whose wrinkles improved by at least one grade on both cheeks, judged by a blinded evaluator 12 months after the first treatment. The estimated responder rate was 70.7% with Sculptra versus 25.9% without treatment. The control group received no injection at all, so the trial does not compare Sculptra with other fillers.
| Item | Sculptra | No treatment |
|---|---|---|
| At least 1-grade improvement on both cheeks | 70.7% | 25.9% |
149 adults randomized 2:1; blinded evaluator; multiple-imputation estimate. Observed: 63 of 88 vs 12 of 46.
Source: FDA Summary of Safety and Effectiveness Data, PMA P030050/S039, Table 12 (checked on October 6, 2026)
Side effects, with numbers
In the cheek trial, almost every treated person (98.9%) recorded at least one expected reaction in a 28-day diary after a session: tenderness (93.5%), bruising (93.5%), swelling (87.1%) and pain, including burning (83.9%) were the most common. Nearly all (97.8%) were mild or moderate, and most (76.1%) resolved within 14 days. Investigators judged that 20.6% of treated people had an adverse event related to treatment, most often bruising (11.3%), dizziness (2.1%) and headache (2.1%), all mild or moderate. One person developed small nodules in both cheeks 180 days after her last injection, still present at the end of the study.
Nodules, granulomas and rare serious risks
The FDA summary lists reports from use after approval in the U.S. and abroad. The most important for planning are papules and nodules (small bumps or lumps), sometimes with inflammation or discoloration, which mostly appeared several months after injection, with onset reported from 1 to 2 months to 14 months after the last session; some resolved on their own or with treatment, and larger or persistent ones, for example near the lower eyelid, needed surgical removal. Granulomas (a foreign-body reaction) usually appeared months after injection. Other reports include lack of effect, swelling, pain, infection and abscess, nerve injury including facial nerve paralysis, allergic reactions and angioedema, scarring, asymmetry and tissue death (necrosis).
Visual disturbances, including blurred vision and blindness, are also listed. The FDA warns that all dermal fillers can cause injury to the blood supply if accidentally injected into a blood vessel, leading to tissue death, vision problems including blindness, or stroke, and lists severe allergic reactions among rare risks. Sculptra’s labeling was updated in 2016 to address the risks of intravascular injection of soft tissue fillers.
Who should not use it
The FDA summary lists the contraindications: hypersensitivity to any component; severe allergies with a history of anaphylaxis, or multiple severe allergies; a known history of, or tendency to, keloids or hypertrophic scarring; and, when mixed with lidocaine, allergy to lidocaine or similar local anesthetics. The FDA’s dermal filler guidance says approved fillers are for adults aged 22 and older. Tell the injector about all your health conditions and medicines, including pregnancy or breastfeeding, blood thinners, skin infections and any previous fillers or implants in the area.
Cost and insurance
ASPS reported an average fee of $901 per procedure in 2023 for non-hyaluronic acid fillers, a category that includes Sculptra, Radiesse, Bellafill and Renuva (down from $1,039 in 2022). The number of vials and sessions drives the total, and the cheek trial used up to four sessions, so ask for a written price for the full plan. Cosmetic use is not covered by insurance. Medicare covers dermal injections for facial lipodystrophy syndrome only with FDA-approved fillers, in people with HIV who have depression related to the physical changes of HIV treatment (national coverage determination 250.5, as described in local rule L39051). See the costs hub.
| Item | Value |
|---|---|
| Hyaluronic acid fillers | 5,331,426 |
| Non-hyaluronic acid fillers (incl. Sculptra) | 932,861 |
Non-HA fillers: 932,861 in 2024 vs 924,549 in 2023 (+1%).
Source: ASPS 2024 Procedural Statistics Release, cosmetic minimally invasive procedures (checked on October 6, 2026)
Alternatives
For facial volume, alternatives include hyaluronic acid fillers (ASPS notes non-HA fillers are not as dissolvable as HA fillers), fat grafting and surgical options such as a facelift or neck lift. For body areas, no filler is FDA approved for contouring; the established options are surgical lifts and, for fat, liposuction. For cellulite, see cellulite. The body contouring hub compares all options.
Choosing an injector
The FDA advises choosing a licensed health care provider experienced in dermatology or plastic surgery, never buying fillers online and never injecting yourself. Ask whether the product is genuine Sculptra from the U.S. supply chain, how many treatments they have performed in your area of concern, whether the planned use is within the FDA approval, how they prevent and manage nodules and vascular events, and how many sessions and vials they plan. Our plastic surgeon guide explains credential checks. We never link to sellers of injectables.
Contouring is not weight loss
This treatment changes the shape of a specific area. It does not lead to meaningful overall weight loss or improve metabolic health. Every proven approach to losing weight
Who explores it
FDA approvals (face only): facial fat loss in people with HIV; immune-competent adults with nasolabial folds and other facial wrinkles; fine lines and wrinkles of the cheeks. Body use is not FDA approved; the FDA recommends against fillers for body contouring.
How it works
Microparticles of poly-L-lactic acid injected into the skin gradually stimulate the body's own collagen production, restoring volume and softening wrinkles over months (FDA, ASPS).
Typical results
Cheek trial (P030050/S039): 70.7% vs 25.9% responders (at least 1-grade improvement on both cheeks) at 12 months, with an average of 3.6 sessions.
Ranges from published studies; individual results vary.
Recovery
Tenderness, bruising, swelling and pain in most people, 76.1% resolved within 14 days; nodules can appear months later (FDA SSED).
Risks
- Diary reactions: tenderness 93.5%, bruising 93.5%, swelling 87.1%, pain 83.9% (cheek trial)
- Papules and nodules, often months after injection; some need surgical removal
- Granulomas (foreign-body reaction)
- Injection into a blood vessel: tissue death, vision problems including blindness, stroke (FDA, all fillers)
- Allergic reactions including angioedema; infection; nerve injury
FDA authorization
| Device | Pathway | Number | Date |
|---|---|---|---|
| Sculptra (HIV facial lipoatrophy) | PMA approval | P030050 | August 3, 2004 |
| Sculptra Aesthetic (nasolabial folds, facial wrinkles) | PMA approval | P030050/S002 | July 28, 2009 |
| Sculptra (cheek fine lines and wrinkles) | PMA approval | P030050/S039 | April 25, 2023 |
Clearance (510(k)) means the FDA found a device similar to one already on the market; it is not the same as approval.
Cost and insurance
| Price | Amount | Basis | Checked on |
|---|---|---|---|
| Typical total (national data) | 901 USD | average fee per non-hyaluronic acid filler procedure (incl. Sculptra), 2023 ASPS | October 6, 2026 |
Prices change often and depend on pharmacy, plan and location. Insurance can change what you pay. Every price shows the date we checked it.
Cosmetic use is not covered. Medicare covers FDA-approved dermal fillers for facial lipodystrophy syndrome in people with HIV who have depression related to it (NCD 250.5, per LCD L39051).
Insurance information checked on October 6, 2026.
Advantages and limitations
Advantages
- FDA-approved device (PMA) for specific facial uses
- Gradual, collagen-based change in volume and wrinkles
- Strong result in a randomized cheek trial (70.7% vs 25.9%)
Limitations
- Several sessions; results build slowly
- Nodules or granulomas can appear months later and may need treatment or removal
- Rare vascular events, including vision loss
- Body uses are not FDA approved; the FDA recommends against fillers for body contouring
Choosing a provider
Check board certification, where the procedure is done (accredited facility), how many of these procedures the provider performs, and what follow-up care is included. Find a Board-Certified Plastic Surgeon for Body Contouring
Alternatives
CosmeticSurgicalLiposuction: what it removes, what it does notSurgical · 1-2 weeks
CosmeticSurgicalArm Lift (Brachioplasty): who it suits, scars, recovery and costSurgical · 1-2 weeks
CosmeticFDA cleared deviceNon-invasiveSkin Tightening: radiofrequency, ultrasound and surgery comparedDevice, non-invasive · NoneRelated procedures
Related guides
“Ozempic Face”: facial changes after fast weight loss"Ozempic face" explained: why fast weight loss changes the face, what the evidence says, what may…
Body Contouring: fat reduction and shaping, surgical and non-surgicalBody contouring explained: non-invasive fat reduction vs surgery, what CoolSculpting, Kybella and liposuction can and cannot…
Find a Board-Certified Plastic Surgeon for Body ContouringHow to find a board-certified plastic surgeon for body contouring after weight loss: ABPS checks, facility…Questions to ask a professional
- Is the area you plan to treat within Sculptra's FDA approval?
- How many sessions and vials do you expect, and what is the total cost?
- How do you prevent and treat nodules and granulomas?
- What is your plan if a vascular event or vision change happens?
- Would a hyaluronic acid filler, fat grafting or surgery suit my goal better?
Frequently asked questions
What is Sculptra approved for?
Only facial uses: restoring facial fat loss in people with HIV (2004), correcting nasolabial folds and other facial wrinkles (2009) and fine lines and wrinkles of the cheeks (2023).
Is a "Sculptra butt lift" FDA approved?
No. No Sculptra approval covers the buttocks or other body areas, and the FDA recommends against using dermal fillers or any injectable filler for body contouring and enhancement, such as the buttocks or breasts.
How does Sculptra work?
Its poly-L-lactic acid microparticles stimulate the body to make new collagen, so results build gradually over a series of sessions rather than appearing immediately.
How many Sculptra sessions are needed?
In the cheek-wrinkle trial people had up to four sessions, an average of 3.6. Your injector sets the plan based on your face and the response.
What are the side effects?
Most people had tenderness, bruising, swelling and pain after sessions, usually mild and gone within two weeks. Nodules and granulomas can appear months later. Rare risks include vascular injury, vision loss and allergic reactions.
Can Sculptra help Ozempic face?
Sculptra is approved for facial wrinkles and facial volume loss related to HIV. Whether it suits face changes after weight loss is a question for an experienced injector; ASPS reports that a third of its surgeons use biostimulatory injectables for facial rejuvenation.
How much does Sculptra cost?
ASPS reported an average of $901 per non-hyaluronic acid filler procedure in 2023. Several sessions are usually needed; ask for a written total.
Who should not get Sculptra?
The FDA lists hypersensitivity to its components, severe allergies with a history of anaphylaxis, a tendency to keloids or hypertrophic scars, and, when mixed with lidocaine, lidocaine allergy. Approved fillers are for adults 22 and older.
References
- PMA P030050: Sculptra and Sculptra Aesthetic (approval and supplements). U.S. Food and Drug Administration, 2004. (accessed October 6, 2026) Government page
- Summary of Safety and Effectiveness Data, PMA P030050/S039 (cheek wrinkles). U.S. Food and Drug Administration, 2023. (accessed October 6, 2026) Drug label
- Summary of Safety and Effectiveness Data, PMA P030050/S002 (Sculptra Aesthetic). U.S. Food and Drug Administration, 2009. (accessed October 6, 2026) Drug label
- Dermal Fillers (Soft Tissue Fillers). U.S. Food and Drug Administration. (accessed October 6, 2026) Government page
- LCD L39051: Cosmetic and Reconstructive Surgery (revision effective 2026-08-27). Centers for Medicare and Medicaid Services. (accessed October 6, 2026) Government page
- 2025 ASPS Procedural Statistics Release. American Society of Plastic Surgeons, 2026. (accessed October 7, 2026) Society statement
- 2024 ASPS Procedural Statistics Release (archived copy captured 2026-01-02). American Society of Plastic Surgeons, 2025. (accessed October 7, 2026) Society statement
- 2023 ASPS Procedural Statistics Release (archived copy). American Society of Plastic Surgeons, 2024. (accessed October 7, 2026) Society statement
Facts checked on October 6, 2026
Educational information, not medical advice. Talk with a qualified healthcare professional about your own situation. In an emergency call 911.